Loading...
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
Ugurel, S ; Rohmel, J ; Ascierto, PA ; Becker, JC ; Flaherty, KC ; Grob, JJ ; Hauschild, A ; Larkin, J ; Livingstone, E ; Long, GV ... show 7 more
Ugurel, S
Rohmel, J
Ascierto, PA
Becker, JC
Flaherty, KC
Grob, JJ
Hauschild, A
Larkin, J
Livingstone, E
Long, GV
Citations
Altmetric:
Abstract
Description
Date
2020
Publisher
Collections
Keywords
Type
Article
Citation
Ugurel S, Rohmel J, Ascierto PA, Becker JC, Flaherty KT, Grob JJ, et al. Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019. Eur J Cancer. 2020;130:126-38.